-+ 0.00%
-+ 0.00%
-+ 0.00%

Biodesix Q3 2024 GAAP EPS $(0.07), Inline, Sales $18.151M Miss $18.611M Estimate

Benzinga·11/01/2024 10:03:38
Listen to the news
Biodesix (NASDAQ:BDSX) reported quarterly losses of $(0.07) per share which met the analyst consensus estimate. The company reported quarterly sales of $18.151 million which missed the analyst consensus estimate of $18.611 million by 2.47 percent. This is a 34.54 percent increase over sales of $13.491 million the same period last year.